NM
Natesavalavan Monalisa
About Natesavalavan Monalisa
Data last updated:
Natesavalavan Monalisa is a Director at Larivin Pharma Private Limited (since 2024). The company operates in Paper. Larivin Pharma Private Limited reported revenue of ₹12.83 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 May 2024 | 2023 | ₹12.83 Cr (FY 2024) | Active |
Board colleagues of Natesavalavan Monalisa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramaiyan Natesavalavan | 01892729 | Larivin Pharma Private Limited | Director |
| Saravanan Haritha | 11082366 | Larivin Pharma Private Limited | Director |
| Saravanan Nambiyappan | 02057224 | Larivin Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Natesavalavan Monalisa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Natesavalavan Monalisa
Natesavalavan Monalisa currently holds 1 directorship: Larivin Pharma Private Limited (Director, since 14 May 2024, revenue ₹12.83 Cr (FY 2024)).
Natesavalavan Monalisa was first appointed on 14 May 2024 as Director at Larivin Pharma Private Limited.
The current boards of Natesavalavan Monalisa's companies include Ramaiyan Natesavalavan (Larivin Pharma Private Limited), Saravanan Haritha (Larivin Pharma Private Limited), Saravanan Nambiyappan (Larivin Pharma Private Limited).